Celularity Stock Revenue
CELUW Stock | USD 0.02 0.0006 3.97% |
Celularity fundamentals help investors to digest information that contributes to Celularity's financial success or failures. It also enables traders to predict the movement of Celularity Stock. The fundamental analysis module provides a way to measure Celularity's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Celularity stock.
Last Reported | Projected for Next Year | ||
Total Revenue | 22.8 M | 21.5 M |
Celularity | Revenue |
Celularity Company Revenue Analysis
Celularity's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Celularity Revenue | 22.77 M |
Most of Celularity's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Celularity is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Celularity Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for Celularity is extremely important. It helps to project a fair market value of Celularity Stock properly, considering its historical fundamentals such as Revenue. Since Celularity's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Celularity's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Celularity's interrelated accounts and indicators.
-0.09 | -0.88 | 0.14 | 0.0 | 0.79 | ||
-0.09 | 0.02 | -0.7 | -0.01 | 0.09 | ||
-0.88 | 0.02 | -0.18 | -0.03 | -0.51 | ||
0.14 | -0.7 | -0.18 | 0.64 | -0.2 | ||
0.0 | -0.01 | -0.03 | 0.64 | -0.02 | ||
0.79 | 0.09 | -0.51 | -0.2 | -0.02 |
Click cells to compare fundamentals
Celularity Revenue Historical Pattern
Today, most investors in Celularity Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Celularity's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Celularity revenue as a starting point in their analysis.
Celularity Revenue |
Timeline |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Competition |
Celularity Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, Celularity reported 22.77 M of revenue. This is 99.7% lower than that of the Biotechnology sector and 96.93% lower than that of the Health Care industry. The revenue for all United States stocks is 99.76% higher than that of the company.
Celularity Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Celularity's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Celularity could also be used in its relative valuation, which is a method of valuing Celularity by comparing valuation metrics of similar companies.Celularity is currently under evaluation in revenue category among its peers.
Celularity Fundamentals
Return On Equity | -1.54 | ||||
Return On Asset | -0.15 | ||||
Profit Margin | (2.64) % | ||||
Operating Margin | (0.84) % | ||||
Number Of Shares Shorted | 175.73 K | ||||
Revenue | 22.77 M | ||||
EBITDA | (35.91 M) | ||||
Net Income | (196.29 M) | ||||
Cash And Equivalents | 38 M | ||||
Cash Per Share | 0.27 X | ||||
Total Debt | 39.24 M | ||||
Debt To Equity | 0.18 % | ||||
Current Ratio | 2.29 X | ||||
Book Value Per Share | 1.27 X | ||||
Cash Flow From Operations | (38.69 M) | ||||
Earnings Per Share | (0.87) X | ||||
Number Of Employees | 120 | ||||
Beta | 0.51 | ||||
Total Asset | 143.89 M | ||||
Retained Earnings | (841.79 M) | ||||
Working Capital | (47.51 M) | ||||
Net Asset | 143.89 M |
About Celularity Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Celularity's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Celularity using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Celularity based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Celularity Stock Analysis
When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.